Buscador de publicacions

Publicacions

  • Núñez R, Álvarez-Román MT, Bonanad S, González-Porras JR, De La Corte-Rodriguez H, Berrueco R and Jiménez-Yuste V.

    The Limitations and Unmet Needs of the Five Cornerstones to Guarantee Lifelong Optimization of Prophylaxis in Hemophilia Patients.

    th open : companion journal to thrombosis and haemostasis . 6(4): 365-377. Nº de cites: 1

    [doi:10.1055/s-0042-1757745]

  • Hinojosa J, Simó-Nebot M, Armero-Campos G, Becerra MV, Alamar AM, Candela-Cantó SA, Culebras D, Muchart-Lopez J and Berrueco R.

    Hemophilia and non-accidental head trauma in two siblings: lessons and legal implications

    CHILDS NERVOUS SYSTEM . 38(12): 2415-2423.

    [doi:10.1007/s00381-022-05713-2]

  • Solsona M, Berrueco R, Sebastián E, Cervera A, Sastre A, Astigarraga I, Argilés B, Dasí MA, Dapena JL and Monteagudo E.

    Tapering of the thrombopoietin receptor agonist in paediatric patients with chronic immune thrombocytopenia: Is it possible?

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . 88(9): 4220-4223.

    [doi:10.1111/bcp.15378]

  • Megías-Vericat JE, Bonanad Boix S, Berrueco R, Mingot-Castellano ME, Rodríguez López M, Canaro Hirnyk M, Mateo Arranz J, Calvo Villas JM, Haya Guaita S, Mesegue-Meda M, López Jaime F, Albo-López C, Palomero-Massanet A, Vilalta Seto N, Leciñena IL, Haro ARC and Poveda Andrés JL.

    Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products

    THROMBOSIS RESEARCH . 216: 35-42. Nº de cites: 4

    [doi:10.1016/j.thromres.2022.06.001]

  • Ruiz-Llobet A, Gassiot S, Sarrate E, Zubicaray J, Dapena JL, Rives-Solà S, Sevilla J, Menárguez López Á, Panesso Romero M, Montoya C, Vagace JM, Molina Hurtado JR, García-Morín M, García Abós M, Mendoza Sánchez MC, Lendínez F, Palomo Moraleda P, Tallón M, González B, Urrutia E, Serna JV, Peláez Pleguezuelos I, Martínez Merino M, Ramos Elbal E, Orellana E, Benítez Muñoz H and Berrueco R.

    Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013

    JOURNAL OF THROMBOSIS AND HAEMOSTASIS . 20(6): 1390-1399. Nº de cites: 5

    [doi:10.1111/jth.15699]

  • Bernal S, Pelaez I, Alias L, Baena M, De Pablo-Moreno JA, Serrano LJ, Camero MD, Tizzano EF, Berrueco R and Liras A.

    High Mutational Heterogeneity, and New Mutations in the Human Coagulation Factor V Gene. Future Perspectives for Factor V Deficiency Using Recombinant and Advanced Therapies

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 22(18): 9705. Nº de cites: 6

    [doi:10.3390/ijms22189705]

  • Gassiot S, Ruiz-Llobet A, Suleman W, Sarrate E and Berrueco R.

    Thrombin generation in children using ThromboScreen reagent kit with ST Genesia-A pilot study

    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY . 43(6): 1612-1619. Nº de cites: 1

    [doi:10.1111/ijlh.13668]

  • Berrueco R, Sebastián E, Solsona M, González de Pablo J, Ruiz-Llobet A, Mesegue-Meda M, Gálvez E and Sevilla J.

    Secondary immune thrombocytopenia in children: Characteristics and outcome of a large cohort from two Spanish centres

    ACTA PAEDIATRICA . 110(6): 1952-1958. Nº de cites: 2

    [doi:10.1111/apa.15765]

  • Bardón Cancho EJ, García-Morín M, Beléndez C, Velasco P, Benéitez D, Ruiz-Llobet A, Berrueco R, Argilés B, Cervera Á, Salinas JA, Vecilla C, Gondra A, Vallés G, Murciano T, Bermúdez M and Cela E.

    Update of the Spanish registry of haemoglobinopathies in children and adults

    MEDICINA CLINICA . 155(3): 95-103. Nº de cites: 12

    [doi:10.1016/j.medcli.2019.10.011]

  • Santoro C, Fuh B, Le PQ, Maes P, Berrueco R, Mingot-Castellano EM, von Mackensen S, Solms A and Wang M.

    BAY 81-8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study

    EUROPEAN JOURNAL OF HAEMATOLOGY . 105(2): 164-172. Nº de cites: 3

    [doi:10.1111/ejh.13420]